Cargando…
Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis
Excision repair cross complementing 1 (ERCC1) and xeroderma pigmentosum group D (XPD) play important roles in the nucleotide excision repair (NER) pathway. The correlation between ERCC1 polymorphisms (rs11615 and rs3212986) and XPD polymorphisms (rs13181 and rs1799793) with the response rate and ove...
Autores principales: | Qixing, Mao, Gaochao, Dong, Wenjie, Xia, Rong, Yin, Feng, Jiang, Lin, Xu, Mantang, Qiu, Qiang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616831/ https://www.ncbi.nlm.nih.gov/pubmed/26426637 http://dx.doi.org/10.1097/MD.0000000000001593 |
Ejemplares similares
-
Prognostic value of platelet-to-lymphocyte ratio in neoadjuvant chemotherapy for solid tumors: A PRISMA-compliant meta-analysis
por: Long, Yuming, et al.
Publicado: (2021) -
Prognostic value of MSI2 expression in human malignancies: A PRISMA-compliant meta-analysis
por: Wu, Wei, et al.
Publicado: (2022) -
The association between polymorphisms in the PDCD1 gene and the risk of cancer: A PRISMA-compliant meta-analysis
por: Zhang, Jie, et al.
Publicado: (2016) -
Association between the polymorphisms in XPG gene and gastric cancer susceptibility in Chinese populations: A PRISMA-compliant meta-analysis
por: Xia, Jun, et al.
Publicado: (2017) -
No association of TNF-α-308G/A polymorphisms with head and neck cancer risk: A PRISMA-compliant meta-analysis
por: Yuan, Cheng, et al.
Publicado: (2017)